CLINICAL_TRIALS
trial_result
· 2012-05-25
Clinical Trial Update: Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer [Phase 2]
Summary
Phase II trial evaluating weekly or every-3-week ixabepilone in metastatic breast cancer has completed with results posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: R-Pharm | Conditions: Metastatic Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2012-05-25